000 01435 a2200409 4500
005 20250512005609.0
264 0 _c19890405
008 198904s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(89)91368-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAdams, D H
245 0 0 _aSoluble interleukin-2 receptors in serum and bile of liver transplant recipients.
_h[electronic resource]
260 _bLancet (London, England)
_cMar 1989
300 _a469-71 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aBile
_xanalysis
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aChronic Disease
650 0 4 _aGraft Rejection
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aKidney Transplantation
650 0 4 _aLymphocyte Activation
650 0 4 _aPostoperative Complications
_xblood
650 0 4 _aPredictive Value of Tests
650 0 4 _aReceptors, Interleukin-2
_xanalysis
650 0 4 _aSerum Albumin
_xanalysis
650 0 4 _aTime Factors
700 1 _aWang, L
700 1 _aHubscher, S G
700 1 _aElias, E
700 1 _aNeuberger, J M
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8636
_gp. 469-71
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(89)91368-8
_zAvailable from publisher's website
999 _c2569789
_d2569789